BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37942405)

  • 1. A Rare Case of Lambert-Eaton Myasthenia Syndrome Associated with Non-Hodgkin's Lymphoma: A Case Report and Review of the Literature.
    Abu-Tineh M; Alamin MA; Aljaloudi E; Alshurafa A; Garcia-Cañibano B; Taha RY; Elkourashy SA
    Case Rep Oncol; 2023; 16(1):1300-1305. PubMed ID: 37942405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.
    Schoser B; Eymard B; Datt J; Mantegazza R
    J Neurol; 2017 Sep; 264(9):1854-1863. PubMed ID: 28608304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual paraneoplastic syndromes in pancreatic cancer: a case report of Lambert-Eaton myasthenic syndrome (LEMS) associated with intraductal papillary mucinous cancer of the pancreas.
    Zamparas A; Herzog T; Förster S; Siglienti I; Uhl W; Strotmann J; Höhn P
    AME Case Rep; 2023; 7():35. PubMed ID: 37942046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lambert-Eaton myasthenic syndrome in a patient with small-cell lung cancer: A case report.
    Zhang RR; Han T; Guo F; Liu ZZ; Han YL; Chen WC; Liu YY; Xie XD
    Oncol Lett; 2015 Sep; 10(3):1339-1342. PubMed ID: 26622673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome.
    Shimizu F; Takeshita Y; Sano Y; Hamamoto Y; Shiraishi H; Sato T; Yoshimura S; Maeda T; Fujikawa S; Nishihara H; Kitanosono H; Tsujino A; Motomura M; Kanda T
    Brain; 2019 Aug; 142(8):2253-2264. PubMed ID: 31236596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
    Kitanosono H; Shiraishi H; Motomura M
    Brain Nerve; 2018 Apr; 70(4):341-355. PubMed ID: 29632282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lambert-Eaton Myasthenic Syndrome.
    Kesner VG; Oh SJ; Dimachkie MM; Barohn RJ
    Neurol Clin; 2018 May; 36(2):379-394. PubMed ID: 29655456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lambert-Eaton myasthenic syndrome - diagnosis, pathogenesis and therapy.
    Hülsbrink R; Hashemolhosseini S
    Clin Neurophysiol; 2014 Dec; 125(12):2328-36. PubMed ID: 25065299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
    Sakai W; Nakane S; Matsuo H
    Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic Disorders: Lambert-Eaton Myasthenic Syndrome and Botulism.
    Gable KL; Massey JM
    Semin Neurol; 2015 Aug; 35(4):340-6. PubMed ID: 26502758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lambert-Eaton myasthenic syndrome.
    Lipka AF; Verschuuren JJGM
    Handb Clin Neurol; 2024; 200():307-325. PubMed ID: 38494285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Favourable outcome after treatment with rituximab in a case of seronegative non-paraneoplastic Lambert-Eaton myasthenic syndrome].
    Boutin E; Rey C; Romeu M; Pouget J; Franques J
    Rev Med Interne; 2013 Aug; 34(8):493-6. PubMed ID: 23759215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lambert-Eaton myasthenic syndrome, an immune pathology of neuromuscular junctions].
    Honnorat J
    Bull Acad Natl Med; 2014 Feb; 198(2):243-54; discussion 255. PubMed ID: 26263702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lambert-Eaton myasthenic syndrome (LEMS)].
    Suzuki S
    Brain Nerve; 2010 Apr; 62(4):419-26. PubMed ID: 20420183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lambert-Eaton myaesthenic syndrome: a possible association with Hodgkin's lymphoma.
    Tyagi A; Connolly S; Hutchinson M
    Ir Med J; 2001 Jan; 94(1):18-9. PubMed ID: 11322220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lambert-Eaton myasthenic syndrome: diagnosis and treatment].
    Motomura M; Iwanaga H
    Clin Calcium; 2001 Nov; 11(11):1468-74. PubMed ID: 15775666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.
    Flink MT; Atchison WD
    J Bioenerg Biomembr; 2003 Dec; 35(6):697-718. PubMed ID: 15000529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voltage gated calcium channel antibody-related neurological diseases.
    Bekircan-Kurt CE; Derle Çiftçi E; Kurne AT; Anlar B
    World J Clin Cases; 2015 Mar; 3(3):293-300. PubMed ID: 25789302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lambert-Eaton myasthenic syndrome].
    Motomura M; Fukuda T
    Brain Nerve; 2011 Jul; 63(7):745-54. PubMed ID: 21747145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lambert-Eaton myasthenic syndrome with primary thymic marginal zone B-cell lymphoma: A case report.
    Soma T; Matsumoto A; Shoji T; Katakura H
    Respirol Case Rep; 2023 May; 11(5):e01149. PubMed ID: 37082169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.